Psoriasis Vulgaris clinical trials

Explore recruiting psoriasis vulgaris clinical trials.

Recruiting psoriasis vulgaris studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Psoriasis Vulgaris trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AN INVESTIGATOR-INITIATED, PHASE 4, OPEN-LABEL, SINGLE-ARM, SINGLE-CENTER STUDY INVESTIGATING THE TISSUE-RESIDENT MEMORY T-CELLS AND DISEASE MEMORY IN PSORIASIS SKIN DURING GUSELKUMAB TREATMENT. THE GUSMEM STUDY.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and of one ointment without active substances for patients with chronic stable plaque poriasis

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adults with psoriasis vulgaris or psoriatic arthritis

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Safety and immunogenicity of Shingrix vaccination in patients suffering from Psoriasis or Psoriatic arthritis

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Psoriasis Vulgaris trials by city

Psoriasis Vulgaris in Toronto Psoriasis Vulgaris in Vancouver Psoriasis Vulgaris in Montreal Psoriasis Vulgaris in Calgary Psoriasis Vulgaris in Edmonton Psoriasis Vulgaris in Ottawa Psoriasis Vulgaris in Winnipeg Psoriasis Vulgaris in Quebec City Psoriasis Vulgaris in Hamilton Psoriasis Vulgaris in Kitchener Psoriasis Vulgaris in London Psoriasis Vulgaris in Halifax Psoriasis Vulgaris in New York Psoriasis Vulgaris in Los Angeles Psoriasis Vulgaris in Chicago Psoriasis Vulgaris in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease